Orchid Pharma shareholders approve all resolutions at 32nd AGM

Orchid Pharma Limited announced the successful approval of all nine resolutions at its 32nd Annual General Meeting held on September 20, 2025. The resolutions, which included the adoption of financial statements for the year ended March 31, 2025, and the re-appointment of directors and auditors, were passed with significant majority through remote e-voting and e-voting during the meeting.

Resolution No. 1, concerning the adoption of standalone and consolidated financial statements, saw 94.7815% of votes cast in favor. Similarly, resolutions for the re-appointment of Dr. Arjun Dhanuka, Mr. Manoj Kumar Goyal, and Ms. Tanu Singla as independent directors were approved with 99.9996%, 90.9831%, and 90.9859% assent, respectively.

Other key approvals included the ratification of remuneration for the cost auditor and the appointment of the secretarial auditor, both passing with 99.9997% of votes in favor. Resolution No. 8, modifying the terms of utilization of funds from a qualified institution placement, received 86.2577% assent. Resolution No. 9, approving material related party transactions, passed with 99.9850% in favor, with related party votes excluded as per regulations.